Literature DB >> 3012861

Pulmonary adenocarcinoma of fetal type: alternating differentiation argues in favour of a common endodermal stem cell.

H K Müller-Hermelink, E Kaiserling.   

Abstract

Pulmonary adenocarcinoma exhibit different cell types that ultrastructurally, appear to be related to the different epithelial cell types occurring in the terminal lung lobule. The present paper describes the light-microscopical, ultrastructural and immunohistochemical features of a newly defined type of pulmonary adenocarcinoma that resembles an early stage of lung differentiation. The alternating epithelial differentiation within this tumour speaks in favour of a common endodermal stem cell for the different types of epithelial cells within the lung, including endocrine cells. The relationship of this tumour to pulmonary blastoma is discussed.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3012861     DOI： 10.1007/bf00708328

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN： 0174-7398


  25 in total

1.  Embryoma of lungs.

Authors:  W G BARNARD
Journal:  Thorax       Date:  1952-12       Impact factor: 9.139

2.  Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid and ultimobranchial C cells and calcitonin.

Authors:  A G Pearse
Journal:  Proc R Soc Lond B Biol Sci       Date:  1968-05-14

3.  Six cases of well-differentiated adenocarcinoma simulating fetal lung tubules in pseudoglandular stage. Comparison with pulmonary blastoma.

Authors:  T Kodama; Y Shimosato; S Watanabe; T Koide; T Naruke; J Shimase
Journal:  Am J Surg Pathol       Date:  1984-10       Impact factor: 6.394

4.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

5.  Amine and peptide hormone production by lung carcinoid: a clinicopathological and immunocytochemical study.

Authors:  F T Bosman; A B de la Riviere; R W Giard; A A Verhofstad; G Cramer-Knijnenburg
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

6.  Phenotypic dynamics of tumor progression in human malignant melanoma.

Authors:  E B Bröcker; L Suter; J Brüggen; D J Ruiter; E Macher; C Sorg
Journal:  Int J Cancer       Date:  1985-07-15       Impact factor: 7.396

7.  Insular carcinoid of ovary associated with malignant mucinous tumors.

Authors:  S J Robboy
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

Review 8.  Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms.

Authors:  V E Gould; R I Linnoila; V A Memoli; W H Warren
Journal:  Lab Invest       Date:  1983-11       Impact factor: 5.662

9.  Lung tumour cell lines synthesizing peptide hormones established from tumours of four histological types: characterization of the cell lines and analysis of their peptide hormone production.

Authors:  W Luster; C Gropp; H F Kern; K Havemann
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

10.  Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross-reacting antibodies.

Authors:  A M Gown; A M Vogel
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539
View more
  2 in total

1.  Pulmonary well-differentiated fetal adenocarcinoma expressing lineage-specific transcription factors (TTF-1 and GATA-6) to respiratory epithelial differentiation: an immunohistochemical and ultrastructural study.

Authors:  Kazuto Yamazaki
Journal:  Virchows Arch       Date:  2003-04-04       Impact factor: 4.064

2.  Primary pulmonary blastoma of monophasic variety--diagnosis and management.

Authors:  Jitendra H Mistry; Sumita B Pawar; Harshad Mehta; Aron Frederik Popov; Prashant Nanasaheb Mohite
Journal:  J Cardiothorac Surg       Date:  2013-06-07       Impact factor: 1.637
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.